Suppr超能文献

肝性脑病中的新旧诱因:对一个不断发展领域的新审视

Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution.

作者信息

Bellafante Daniele, Gioia Stefania, Faccioli Jessica, Riggio Oliviero, Ridola Lorenzo, Nardelli Silvia

机构信息

Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Roma, Italy.

出版信息

J Clin Med. 2023 Feb 2;12(3):1187. doi: 10.3390/jcm12031187.

Abstract

Hepatic encephalopathy (HE) is a common complication in patients with advanced liver disease. It is a brain dysfunction characterized by neurological and psychiatric symptoms that significantly affects quality of life, morbidity and mortality of patients. HE has various precipitants that can potentially promote its onset, alone or in combination. Among the historically well-known precipitants, such as infections, gastrointestinal bleeding, dehydration, electrolyte disorders and constipation, recent studies have highlighted the role of malnutrition and portosystemic shunts as new precipitating factors of HE. The identification, management and correction of these factors are fundamental for effective HE treatment, in addition to pharmacological therapy with non-absorbable disaccharides and/or antibiotics.

摘要

肝性脑病(HE)是晚期肝病患者常见的并发症。它是一种以神经和精神症状为特征的脑功能障碍,严重影响患者的生活质量、发病率和死亡率。HE有多种促发因素,这些因素单独或共同作用都可能促使其发病。在诸如感染、胃肠道出血、脱水、电解质紊乱和便秘等历史上广为人知的促发因素中,最近的研究强调了营养不良和门体分流作为HE新的促发因素的作用。除了使用不可吸收的二糖和/或抗生素进行药物治疗外,识别、管理和纠正这些因素对于有效治疗HE至关重要。

相似文献

3
A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.肝硬化中显性肝性脑病诱因的新视角
Dig Dis Sci. 2017 Aug;62(8):2166-2173. doi: 10.1007/s10620-017-4630-y. Epub 2017 May 30.
4
Management of overt hepatic encephalopathy.显性肝性脑病的管理
J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S82-7. doi: 10.1016/j.jceh.2014.04.004. Epub 2014 May 10.
5
Hepatic Encephalopathy: Diagnosis and Management.肝性脑病:诊断与管理
J Transl Int Med. 2020 Dec 31;8(4):210-219. doi: 10.2478/jtim-2020-0034. eCollection 2020 Dec.
6
Management of Hepatic Encephalopathy Not Responsive to First-Line Treatments.对一线治疗无反应的肝性脑病的管理
Curr Treat Options Gastroenterol. 2018 Jun;16(2):253-259. doi: 10.1007/s11938-018-0183-1.
8
Management of hepatic encephalopathy in the hospital.医院中肝性脑病的管理。
Mayo Clin Proc. 2014 Feb;89(2):241-53. doi: 10.1016/j.mayocp.2013.11.009. Epub 2014 Jan 8.
9
[Hepatic encephalopathy].[肝性脑病]
Recenti Prog Med. 2016 Jul;107(7):378-85. doi: 10.1701/2318.24932.
10
Hepatic encephalopathy therapy: An overview.肝性脑病治疗:概述
World J Gastrointest Pharmacol Ther. 2010 Apr 6;1(2):54-63. doi: 10.4292/wjgpt.v1.i2.54.

本文引用的文献

3
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.EASL 临床实践指南:肝性脑病管理。
J Hepatol. 2022 Sep;77(3):807-824. doi: 10.1016/j.jhep.2022.06.001. Epub 2022 Jun 17.
5
Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.肝硬化患者低钠血症的临床意义、评估及管理
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):575-594. doi: 10.1016/j.jceh.2021.09.008. Epub 2021 Sep 16.
6
Gut Barrier and Microbiota in Cirrhosis.肝硬化中的肠道屏障与微生物群
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):625-638. doi: 10.1016/j.jceh.2021.08.027. Epub 2021 Sep 3.
10
Baveno VII - Renewing consensus in portal hypertension.《巴韦诺 VII 共识:门静脉高压领域的新共识》
J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验